Skip to main content

Home/ health information/ Group items tagged Valproate-bipolar-disorder

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
pharmacybiz

Valproate Dispensing Update: Safety First - 0 views

www.pharmacy.biz/...s-now-come-with-safety-warning

Valproate-containing-medicines Valproate-epilepsy-treatment Valproate-bipolar-disorder Valproate-patient-safety Valproate-medical-guidelines Valproate-dispensing-guidelines

shared by pharmacybiz on 14 Oct 23 - No Cached
  • pharmacybiz on 14 Oct 23
     
    The Department of Health and Social Care (DHSC) and the Medicines and Healthcare Products Regulatory Agency (MHRA) have authorised community pharmacies throughout the UK to dispense original full packs of Valproate-containing medicines upon prescription. The necessary changes in regulations came into effect on 11 October which was strongly supported by 85 per cent of respondents concerned about risks to the unborn baby if valproate-containing medicines are used in pregnancy. The decision was made to ensure patients receive safety warnings and pictograms, including a patient card and the Patient Information Leaflet (PIL), contained in the manufacturer's original full pack. Valproate is a treatment for epilepsy and bipolar disorder but is also associated with birth defects and neurological disabilities.
Alex Parker

Dainippon's Latuda gets approval in Canada to treat bipolar depression - 1 views

regulatoryaffairs.pharmaceutical-business-review.com/...olar-depression-040414-4209058

health treatment

shared by Alex Parker on 04 Apr 14 - No Cached
  • Alex Parker on 04 Apr 14
     
    Dainippon Sumitomo Pharma (DSP) has received approval from Health Canada for use of Latuda (lurasidone HCl) as monotherapy or as adjunctive therapy with lithium or valproate to treat depressive episodes associated with bipolar I disorder.
1 - 2 of 2
Showing 20▼ items per page